Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (381-390 of 569) with videos related to

Pageof 57
Sort By:
Pigment Cell & Melanoma Research|December 11, 2014
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosisVarsha Tembe, Sarah-Jane Schramm, Mitchell S Stark, et al.
Pigment Cell & Melanoma Research|December 6, 2014
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trialsJason Madore, Ricardo E Vilain, Alexander M Menzies, et al.
Annals of Surgical Oncology|November 20, 2014
Sex differences in melanoma survival are not related to mitotic rate of the primary tumorArjen Joosse, Augustinus P T van der Ploeg, Lauren E Haydu, et al.
Annals of Surgical Oncology|February 10, 2022
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III MelanomaMbathio Dieng, Sarah J Lord, Robin M Turner, et al.
Annals of Surgical Oncology|April 9, 2004
The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-upAnne Brecht Francken, Helen M Shaw, John F Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2016
Plasma cells in primary melanoma. Prognostic significance and possible role of IgAFrancesca M Bosisio, James S Wilmott, Nathalie Volders, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 22, 2013
Margins of excision and prognostic factors for cutaneous eyelid melanomasVarun Harish, Jeremy S Bond, Richard A Scolyer, et al.
Cancer|July 29, 2015
Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsAlexander M Menzies, James S Wilmott, Martin Drummond, et al.
Annals of Surgery|March 18, 2014
Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institutionAugustinus P T van der Ploeg, Lauren E Haydu, Andrew J Spillane, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2014
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumorsAllison R Larson, Karen A Dresser, Qian Zhan, et al.
Pageof 57

Showing results (381-390 of 569) with videos related to

Sort By:
Pageof 57
Pigment Cell & Melanoma Research|December 11, 2014
MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosisVarsha Tembe, Sarah-Jane Schramm, Mitchell S Stark, et al.
Pigment Cell & Melanoma Research|December 6, 2014
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trialsJason Madore, Ricardo E Vilain, Alexander M Menzies, et al.
Annals of Surgical Oncology|November 20, 2014
Sex differences in melanoma survival are not related to mitotic rate of the primary tumorArjen Joosse, Augustinus P T van der Ploeg, Lauren E Haydu, et al.
Annals of Surgical Oncology|February 10, 2022
The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III MelanomaMbathio Dieng, Sarah J Lord, Robin M Turner, et al.
Annals of Surgical Oncology|April 9, 2004
The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-upAnne Brecht Francken, Helen M Shaw, John F Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 13, 2016
Plasma cells in primary melanoma. Prognostic significance and possible role of IgAFrancesca M Bosisio, James S Wilmott, Nathalie Volders, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 22, 2013
Margins of excision and prognostic factors for cutaneous eyelid melanomasVarun Harish, Jeremy S Bond, Richard A Scolyer, et al.
Cancer|July 29, 2015
Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitorsAlexander M Menzies, James S Wilmott, Martin Drummond, et al.
Annals of Surgery|March 18, 2014
Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institutionAugustinus P T van der Ploeg, Lauren E Haydu, Andrew J Spillane, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2014
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumorsAllison R Larson, Karen A Dresser, Qian Zhan, et al.
Pageof 57